Scott Dalgleish Appointed Chief Financial Officer of The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation has named Scott Dalgleish Chief Financial Officer, overseeing the finance function, including revenue cycle management, accounting, and financial planning and analysis as well as the dispensary department. Most recently, Scott served as Chief Financial Officer for Providence Health Network and Providence’s St Joseph Heritage Medical Group in California. He formerly held executive level finance roles with ConcertoHealth, DaVita Medical Group and Credit Suisse.
The Oncology Institute of Hope and Innovation is the largest community oncology practice on the west coast, and the nation’s leading value-based oncology services platform. TOI employs over 500 total employees helping to deliver cutting edge, evidence-based cancer care to a population of over 1 million patients. The company is headquartered in Cerritos, CA, and serves patients throughout California, Arizona, and Nevada.